Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,042 public trials 567 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

NCT02331368

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

NCT01789255

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +176 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

NCT02071888

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States

John Theruer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

NCT01484015

Conditions: Adnexal Diseases, Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, +121 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

NCT00001830

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

NCT01526694

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Division of Hematology and CBMT Bolzano, BZ, Italy

Presidio Ospedaliero di Camposampiero Camposampiero, Padova, Italy

Ospedale S. Martino Belluno, Italy

Ospedale di Castelfranco Veneto Castelfranco Veneto, Italy

View all 19 locations

View Trial Details

Completed

Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic Malignancies

NCT01034475

Conditions: Advanced Hematologic Malignancies, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

NCT01053494

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00119392

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients

NCT03569410

Conditions: Blood Protein Disorders, Chronic Disease, Disease Attributes, +19 more
Locations: Kaiser Permanente Riverside Medical Center Riverside, California, United States

View Trial Details

Blood Protein Disorders

Blood Protein Disorders trial results

Related conditions